Patents Assigned to Encore Medical Asset Corporation
-
Patent number: 11541226Abstract: The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.Type: GrantFiled: November 18, 2019Date of Patent: January 3, 2023Assignee: Encore Medical Asset CorporationInventors: Jon E. Beck, Robert F. Hause, Jr.
-
Patent number: 10478610Abstract: The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.Type: GrantFiled: October 17, 2016Date of Patent: November 19, 2019Assignee: Encore Medical Asset CorporationInventors: Jon E. Beck, Robert F. Hause, Jr.
-
Patent number: 9808619Abstract: Electrotherapy systems and methods for delivering an electrostimulation treatment program to a user while reducing the risk of inducing cardiac fibrillation. The systems and methods detect electrostimulation treatment program delivery characteristics, including a pulse intensity above a preset limit; a pulse duration above a preset limit; an inappropriately compensated pulse; a charge per pulse above a predetermined limit; a current improperly exiting from a stimulation channel; a current present outside of a pulse; an excitation pulse and a compensation pulse generated on different channels; an inter-pulse time less than a predetermined limit; and a time between an excitation and a compensation pulse greater than a predetermined limit. The limits are selected in relation to an objective of reducing the risk of inducing cardiac fibrillation.Type: GrantFiled: February 10, 2012Date of Patent: November 7, 2017Assignee: Encore Medical Asset CorporationInventors: Felix Buhlmann, Etienne Dunant, Steve Guex, David Truffer, Pierre-Yves Mueller
-
Patent number: 9757553Abstract: An electrode for an iontophoretic drug delivery system includes a retainer having a malleable characteristic. The retainer and a conductor are connected to a platform. The conductor and a dose controller are electrically coupled to the iontophoretic drug delivery system. A drug delivery matrix is operably connected to the platform and proximate the conductor wherein the conductor, the drug delivery matrix, and the dose controller cooperate to deliver a drug to a user when the electrode is affixed to the user and operably connected to the iontophoretic drug delivery system.Type: GrantFiled: November 6, 2015Date of Patent: September 12, 2017Assignee: Encore Medical Asset CorporationInventors: Ralph Koschinsky, James D. Isaacson, Robert F. Hause
-
Patent number: 9669211Abstract: A method and apparatus for applying neuromuscular electrical stimulation to an agonist/antagonist muscle pair to move a limb about a joint includes generating a first pattern of neuromuscular electrical stimulation pulses for output through a first channel to a first pair of electrodes and generating a second pattern of neuromuscular stimulation pulses for output through a second channel to a second pair of electrodes. The first pair of electrodes are attached to the agonist muscle of the agonist/antagonist muscle pair, and the second pair of electrodes are attached to the antagonist muscle. A first pattern of electrical stimulation pulses is transmitted through the first pair of electrodes to the agonist muscle at a first intensity level to initiate contraction of the agonist muscle, and then at a second intensity level which is less than the first intensity level to continue contraction of the agonist muscle.Type: GrantFiled: May 26, 2016Date of Patent: June 6, 2017Assignee: Encore Medical Asset CorporationInventors: Yorick Wijting, Jeffrey K. Pohl
-
Patent number: 9468757Abstract: The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.Type: GrantFiled: June 3, 2014Date of Patent: October 18, 2016Assignee: Encore Medical Asset CorporationInventors: Jon E. Beck, Robert F. Hause, Jr.
-
Patent number: 9352151Abstract: A method and apparatus for applying neuromuscular electrical stimulation to an agonist/antagonist muscle pair to move a limb about a joint includes generating a first pattern of neuromuscular electrical stimulation pulses for output through a first channel to a first pair of electrodes and generating a second pattern of neuromuscular stimulation pulses for output through a second channel to a second pair of electrodes. The first pair of electrodes are attached to the agonist muscle of the agonist/antagonist muscle pair, and the second pair of electrodes are attached to the antagonist muscle. A first pattern of electrical stimulation pulses is transmitted through the first pair of electrodes to the agonist muscle at a first intensity level to initiate contraction of the agonist muscle, and then at a second intensity level which is less than the first intensity level to continue contraction of the agonist muscle.Type: GrantFiled: December 30, 2013Date of Patent: May 31, 2016Assignee: Encore Medical Asset CorporationInventors: Yorick Wijting, Jeffrey K. Pohl
-
Patent number: 9180286Abstract: An electrode for an iontophoretic drug delivery system includes a retainer having a malleable characteristic. The retainer and a conductor are connected to a platform. The conductor and a dose controller are electrically coupled to the iontophoretic drug delivery system. A drug delivery matrix is operably connected to the platform and proximate the conductor wherein the conductor, the drug delivery matrix, and the dose controller cooperate to deliver a drug to a user when the electrode is affixed to the user and operably connected to the iontophoretic drug delivery system.Type: GrantFiled: May 1, 2013Date of Patent: November 10, 2015Assignee: Encore Medical Asset CorporationInventors: Ralph Koschinsky, James D. Isaacson, Robert F. Hause
-
Patent number: 9084879Abstract: An iontophoretic drug delivery device storage apparatus and a method of using that device is disclosed. The device comprises a fluid reservoir, an electrode assembly and a tray apparatus. The fluid reservoir is capable of retaining a medicament and has a sealed fluid chamber defined by at least one seal. The seal includes a weaker region and a pinch-like configuration associated with that region such that application of pressure to the fluid reservoir breaks the weaker region of the seal, releasing the retained medicament. The electrode assembly comprises an active electrode, at least two passive electrodes a medicament carrying region, and a moat region around the medicament carrying region so that once fluid is delivered from the fluid reservoir to the electrode assembly the fluid is substantially retained in the medicament carrying means.Type: GrantFiled: October 25, 2006Date of Patent: July 21, 2015Assignee: Encore Medical Asset CorporationInventors: Gregory A. Fischer, Malcolm E. Taylor, Edward M. Kolvek
-
Publication number: 20140288482Abstract: The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.Type: ApplicationFiled: June 3, 2014Publication date: September 25, 2014Applicant: Encore Medical Asset CorporationInventors: Jon E. Beck, Robert F. Hause, JR.
-
Patent number: 8819879Abstract: A therapeutic treatment table comprises a frame and a treatment platform that is mounted on the frame and adapted to support at least a portion of the body of a patient. A preferred treatment table also includes an arm support section which is mounted on the frame. The arm support section comprises an arm support that is moveable by a patient on the table independently of the treatment platform.Type: GrantFiled: November 12, 2008Date of Patent: September 2, 2014Assignee: Encore Medical Asset CorporationInventors: Greg Day, Ken Bolam, Jeff Powe, Rainer Teufel
-
Patent number: 8788031Abstract: An iontophoretic drug delivery device storage apparatus and a method of using that device is disclosed. The device comprises a fluid reservoir, an electrode assembly and a tray apparatus. The fluid reservoir is capable of retaining a medicament and has a sealed fluid chamber defined by at least one seal. The seal includes a weaker region and a pinch-like configuration associated with that region such that application of pressure to the fluid reservoir breaks the weaker region of the seal, releasing the retained medicament. The electrode assembly comprises an active electrode, at least two passive electrodes a medicament carrying region, and a moat region around the medicament carrying region so that once fluid is delivered from the fluid reservoir to the electrode assembly the fluid is substantially retained in the medicament carrying means.Type: GrantFiled: October 25, 2006Date of Patent: July 22, 2014Assignee: Encore Medical Asset CorporationInventors: Gregory A. Fischer, Malcolm E. Taylor, Edward M. Kolvek
-
Patent number: 8781572Abstract: The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.Type: GrantFiled: February 14, 2013Date of Patent: July 15, 2014Assignee: Encore Medical Asset CorporationInventors: Robert F. Hause, Jr., Jon E. Beck
-
Publication number: 20140188013Abstract: A method and apparatus for applying neuromuscular electrical stimulation to an agonist/antagonist muscle pair to move a limb about a joint includes generating a first pattern of neuromuscular electrical stimulation pulses for output through a first channel to a first pair of electrodes and generating a second pattern of neuromuscular stimulation pulses for output through a second channel to a second pair of electrodes. The first pair of electrodes are attached to the agonist muscle of the agonist/antagonist muscle pair, and the second pair of electrodes are attached to the antagonist muscle. A first pattern of electrical stimulation pulses is transmitted through the first pair of electrodes to the agonist muscle at a first intensity level to initiate contraction of the agonist muscle, and then at a second intensity level which is less than the first intensity level to continue contraction of the agonist muscle.Type: ApplicationFiled: December 30, 2013Publication date: July 3, 2014Applicant: Encore Medical Asset CorporationInventors: Yorick Wijting, Jeffrey K. Pohl
-
Publication number: 20140039376Abstract: An electrode for an iontophoretic drug delivery system includes a retainer having a malleable characteristic. The retainer and a conductor are connected to a platform. The conductor and a dose controller are electrically coupled to the iontophoretic drug delivery system. A drug delivery matrix is operably connected to the platform and proximate the conductor wherein the conductor, the drug delivery matrix, and the dose controller cooperate to deliver a drug to a user when the electrode is affixed to the user and operably connected to the iontophoretic drug delivery system.Type: ApplicationFiled: May 1, 2013Publication date: February 6, 2014Applicant: ENCORE MEDICAL ASSET CORPORATIONInventor: ENCORE MEDICAL ASSET CORPORATION
-
Patent number: 8620438Abstract: A method and apparatus for applying neuromuscular electrical stimulation to an agonist/antagonist muscle pair to move a limb about a joint includes generating a first pattern of neuromuscular electrical stimulation pulses for output through a first channel to a first pair of electrodes and generating a second pattern of neuromuscular stimulation pulses for output through a second channel to a second pair of electrodes. The first pair of electrodes are attached to the agonist muscle of the agonist/antagonist muscle pair, and the second pair of electrodes are attached to the antagonist muscle. A first pattern of electrical stimulation pulses is transmitted through the first pair of electrodes to the agonist muscle at a first intensity level to initiate contraction of the agonist muscle, and then at a second intensity level which is less than the first intensity level to continue contraction of the agonist muscle.Type: GrantFiled: February 13, 2007Date of Patent: December 31, 2013Assignee: Encore Medical Asset CorporationInventors: Yorick Wijting, Jeffrey K. Pohl
-
Publication number: 20130226135Abstract: The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.Type: ApplicationFiled: February 14, 2013Publication date: August 29, 2013Applicant: ENCORE MEDICAL ASSET CORPORATIONInventor: ENCORE MEDICAL ASSET CORPORATION
-
Patent number: 8447393Abstract: An electrode for an iontophoretic drug delivery system includes a retainer having a malleable characteristic. The retainer and a conductor are connected to a platform. The conductor and a dose controller are electrically coupled to the iontophoretic drug delivery system. A drug delivery matrix is operably connected to the platform and proximate the conductor wherein the conductor, the drug delivery matrix, and the dose controller cooperate to deliver a drug to a user when the electrode is affixed to the user and operably connected to the iontophoretic drug delivery system.Type: GrantFiled: August 5, 2011Date of Patent: May 21, 2013Assignee: Encore Medical Asset CorporationInventors: Ralph Koschinsky, Jim Isaacson, Robert F. Hause
-
Patent number: 8386029Abstract: The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.Type: GrantFiled: March 31, 2005Date of Patent: February 26, 2013Assignee: Encore Medical Asset CorporationInventors: Robert F. Hause, Jr., Jon E. Beck
-
Patent number: 8214030Abstract: An iontophoresis apparatus and method is disclosed that is suited to deliver a plurality of treatment methods such as, but not limited to, body site conductivity enhancement followed by low voltage iontophoresis.Type: GrantFiled: April 10, 2007Date of Patent: July 3, 2012Assignee: Encore Medical Asset CorporationInventors: Robert F. Hause, Jr., Jon E. Beck